Malamut Richard
Insider CIK 1772168 · COLL EVP and Chief Medical Officer · CHRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-04-02 | 2026-04-06 | 280 | $21.36 | $6.0K | 27,422 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-04-02 | 2026-04-06 | 310 | $20.51 | $6.4K | 27,702 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2025-11-13 | 2026-04-01 | 2,454 | — | $0 | 8,904 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 28,012 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 28,012 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| CHRO Chromocell Therapeutics Co | A Award deriv | 2024-11-13 | 2024-11-15 | 24,533 | — | $0 | 116,098 | SEC↗ |
| CHRO Chromocell Therapeutics Co | P Buy | 2024-09-12 | 2024-09-16 | 10,400 | $0.94 | $9.8K | 91,565 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2024-06-14 | 2026-04-01 | 6,450 | — | $0 | 6,450 | SEC↗ |
| CHRO Chromocell Therapeutics Co | A Award deriv | 2024-06-14 | 2024-06-18 | 64,498 | — | $0 | 81,165 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2022-02-10 | 2022-02-14 | 36,750 | — | $0 | 130,308 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2022-02-10 | 2022-02-14 | 1,838 | $17.63 | $32.4K | 130,264 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2022-02-10 | 2022-02-14 | 6,256 | — | $0 | 136,564 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2022-02-10 | 2022-02-14 | 4,462 | $17.63 | $78.7K | 132,102 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2021-04-01 | 2021-04-05 | 3,119 | $23.38 | $72.9K | 93,558 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2021-02-10 | 2021-02-12 | 1,542 | $25.95 | $40.0K | 96,677 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2021-02-10 | 2021-02-12 | 758 | $25.95 | $19.7K | 98,219 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2021-01-19 | 2021-01-21 | 105,600 | — | $0 | 105,600 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-01-19 | 2021-01-21 | 2,187 | — | $0 | 98,977 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-01-19 | 2021-01-21 | 36,960 | — | $0 | 96,790 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-01-19 | 2021-01-22 | 2,187 | — | $0 | 98,977 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-01-19 | 2021-01-22 | 36,960 | — | $0 | 96,790 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | F Tax w/h | 2020-04-01 | 2020-04-03 | 2,920 | $15.49 | $45.2K | 59,830 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2020-02-05 | 2020-02-07 | 22,500 | — | $0 | 22,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2020-02-05 | 2020-02-07 | 20,250 | — | $0 | 62,750 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2019-04-01 | 2019-04-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2019-04-01 | 2019-04-02 | 42,500 | — | $0 | 42,500 | SEC↗ |